Equillium (NASDAQ: EQ) Soars After Positive Results From Clinical Study – TipRanks

Sep 28, 2022 by The Beat Maker - 0 Comments
  1. Equillium (NASDAQ: EQ) Soars After Positive Results From Clinical Study  TipRanks
  2. Why Is Equillium (EQ) Stock Soaring 20% Today?  InvestorPlace
  3. Equillium (EQ) Announces Positive Interim Results from the EQUALISE Study in Subjects with Lupus Nephritis  StreetInsider.com
  4. Here’s Why Equillium Stock Is Skyrocketing – Equillium (NASDAQ:EQ)  Benzinga
  5. View Full Coverage on Google News

source

Leave a Comment